Patents by Inventor Syed Shaukat Husain

Syed Shaukat Husain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anesthetic compounds and related methods of use
    Patent number: 10154991
    Abstract: Provided herein are compounds according to formula (I): Provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: December 18, 2018
    Assignee: Annovation Biopharma, Inc.
    Inventors: Douglas E. Raines, Syed Shaukat Husain, John C. R. Randle
  • ANESTHETIC COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20180098968
    Abstract: Provided herein are compounds according to formula (I): Provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.
    Type: Application
    Filed: October 19, 2017
    Publication date: April 12, 2018
    Applicants: THE GENERAL HOSPITAL CORPORATION, ANNOVATION BIOPHARMA, INC.
    Inventors: Douglas E. RAINES, Syed Shaukat HUSAIN, John C.R. RANDLE
  • Anesthetic compounds and related methods of use
    Patent number: 9820971
    Abstract: Provided herein are compounds according to formula (I): Provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: November 21, 2017
    Assignees: THE GENERAL HOSPITAL CORPORATION, ANNOVATION BIOPHARMA, INC.
    Inventors: Douglas E. Raines, Syed Shaukat Husain, John C. R. Randle
  • ANESTHETIC COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20170273951
    Abstract: Provided herein are compounds according to formula (I): Provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.
    Type: Application
    Filed: November 10, 2016
    Publication date: September 28, 2017
    Applicants: THE GENERAL HOSPITAL CORPORATION, ANNOVATION BIOPHARMA, INC.
    Inventors: Douglas E. RAINES, Syed Shaukat HUSAIN, John C.R. RANDLE
  • Anesthetic compounds and related methods of use
    Patent number: 9522136
    Abstract: Provided herein are compounds according to formula (I): provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: December 20, 2016
    Assignees: THE GENERAL HOSPITAL CORPORATION, ANNOVATION BIOPHARMA, INC.
    Inventors: Douglas E. Raines, Syed Shaukat Husain, John C. R. Randle
  • ANESTHETIC COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20150328189
    Abstract: Provided herein are compounds according to formula (I): provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.
    Type: Application
    Filed: July 24, 2015
    Publication date: November 19, 2015
    Applicants: ANNOVATION BIOPHARMA, LLC., THE GENERAL HOSPITAL CORPORATION
    Inventors: Douglas E. RAINES, Syed Shaukat HUSAIN, John C.R. RANDLE
  • Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
    Patent number: 9181197
    Abstract: The invention is directed to compounds according to formula (I): where R1 is L1C(O)OT or L1C(O)OL2C(O)OT; R2 is a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, or R1; n is an integer from 0 to 5; each R3 is independently halogen or R2; L1 and L2 are each independently a bond, a substituted or unsubstituted C1-C10 alkylene, C2-C10 alkenylene, or C2-C10 alkynylene; and T is H, a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, nitrophenol, or cyclopropyl. The invention is also directed to a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and to methods for providing anesthesia in mammals by administering such a pharmaceutical composition.
    Type: Grant
    Filed: September 13, 2013
    Date of Patent: November 10, 2015
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Douglas E. Raines, Stuart A. Forman, Keith W. Miller, Syed Shaukat Husain, Joseph F. Cotten
  • Anesthetic compounds and related methods of use
    Patent number: 9156825
    Abstract: Provided herein are compounds according to formula (I): Provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: October 13, 2015
    Assignees: THE GENERAL HOSPITAL CORPORATION, ANNOVATION BIOPHARMA, LLC
    Inventors: Douglas E. Raines, Syed Shaukat Husain, John C. R. Randle
  • ANESTHETIC COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20150203476
    Abstract: Provided herein are compounds according to formula (I): Provided herein is also a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and a method for providing anesthesia in a subject by administering such a pharmaceutical composition.
    Type: Application
    Filed: January 11, 2013
    Publication date: July 23, 2015
    Inventors: Douglas E. Raines, Syed Shaukat Husain, John C.R. Randle
  • ETOMIDATE ANALOGUES WITH IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES
    Publication number: 20140200251
    Abstract: The invention is directed to compounds according to formula (I): where R1 is L1C(O)OT or L1C(O)OL2C(O)OT; R2 is a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, or R1; n is an integer from 0 to 5; each R3 is independently halogen or R2; L1 and L2 are each independently a bond, a substituted or unsubstituted C1-C10 alkylene, C2-C10 alkenylene, or C2-C10 alkynylene; and T is H, a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, nitrophenol, or cyclopropyl. The invention is also directed to a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and to methods for providing anesthesia in mammals by administering such a pharmaceutical composition.
    Type: Application
    Filed: September 13, 2013
    Publication date: July 17, 2014
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Douglas E. Raines, Stuart A. Forman, Keith W. Miller, Syed Shaukat Husain, Joseph F. Cotten
  • Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
    Patent number: 8557856
    Abstract: The invention is directed to compounds according to formula (I): where R1 is L1C(O)OT or L1C(O)OL2C(O)OT; R2 is a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, or R1; n is an integer from 0 to 5; each R3 is independently halogen or R2; L1 and L2 are each independently a bond, a substituted or unsubstituted C1-C10 alkylene, C2-C10 alkenylene, or C2-C10 alkynylene; and T is H, a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, nitrophenol, or cyclopropyl. The invention is also directed to a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and to methods for providing anesthesia in mammals by administering such a pharmaceutical composition.
    Type: Grant
    Filed: March 31, 2009
    Date of Patent: October 15, 2013
    Assignee: The General Hospital Corporation
    Inventors: Douglas E. Raines, Stuart A. Forman, Keith W. Miller, Syed Shaukat Husain, Joseph F. Cotten
  • ETOMIDATE ANALOGUES WITH IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES
    Publication number: 20110053998
    Abstract: The invention is directed to compounds according to formula (I): where R1 is L1C(O)OT or L1C(O)OL2C(O)OT; R2 is a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, or R1; n is an integer from 0 to 5; each R3 is independently halogen or R2; L1 and L2 are each independently a bond, a substituted or unsubstituted C1-C10 alkylene, C2-C10 alkenylene, or C2-C10 alkynylene; and T is H, a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, nitrophenol, or cyclopropyl. The invention is also directed to a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and to methods for providing anesthesia in mammals by administering such a pharmaceutical composition.
    Type: Application
    Filed: March 31, 2009
    Publication date: March 3, 2011
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Douglas E. Raines, Stuart A. Forman, Keith W. Miller, Syed Shaukat Husain, Joseph F. Cotten